Teva Pharmaceutical Industries Limited (FRA:TEV)

Germany flag Germany · Delayed Price · Currency is EUR
13.45
-0.65 (-4.61%)
Last updated: Aug 1, 2025
-4.61%
Market Cap15.49B
Revenue (ttm)14.16B
Net Income (ttm)-133.69M
Shares Outn/a
EPS (ttm)-0.12
PE Ration/a
Forward PE6.04
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume1,259
Open13.50
Previous Close14.10
Day's Range13.40 - 13.50
52-Week Range11.15 - 21.90
Betan/a
RSI48.52
Earnings DateJul 30, 2025

About Marathon Oil

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com... [Read more]

Industry Pharmaceutical Preparations
Founded 1901
Employees 35,686
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol TEV
Full Company Profile

Financial Performance

In 2024, FRA:TEV's revenue was $16.54 billion, an increase of 4.40% compared to the previous year's $15.85 billion. Losses were -$1.64 billion, 193.2% more than in 2023.

Financial numbers in GBP Financial Statements

News

There is no news available yet.